Roop K. Lakkaraju - 03 Mar 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, Chief Financial Officer
Signature: /s/ Roop K. Lakkaraju
Issuer symbol: BIO
Transactions as of: 03 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2025, 16:59:58 UTC
Previous filing: 03 Mar 2025
Next filing: 25 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BIO BIO.B	Bio-Rad A Common Stock						88	03 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO BIO.B	Non-Qualified Stock Option (right to buy)	Award	$0	+3,891		$0.000000	3,891	03 Mar 2025	Bio-Rad A Common Stock	3,891	$256.45	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 61.7090 and 25.7940 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2024 and 12/31/2024, respectively.
F2	The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.